Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.
Ultromics has raised $55.0M in total funding. The most recent round was Series C. The last funding was announced in July 2025.
Ultromics's investors include UCM Ventures, Lightrock, Optum Ventures, Future Planet Capital, Nina Capital.
Ultromics is headquartered in Oxford, United Kingdom.
Ultromics develops AI-driven cardiology solutions to assist in cardiovascular disease diagnosis through echocardiography.
Ultromics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Ultromics — Funding & Investors." VCBacked, July 31, 2025, https://www.vcbacked.co/company/ultromics. Accessed July 19, 2026.
VCBacked. (2025). Ultromics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/ultromics
{{cite web |title=Ultromics — Funding & Investors |url=https://www.vcbacked.co/company/ultromics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated